tiprankstipranks
Advertisement
Advertisement

STRO Stock Latest News

Analyst Reiterates Buy on Sutro Biopharma, Maintains $54 Price Target on Differentiated ADC Platform and Pipeline Progress
RatingsAnalyst Reiterates Buy on Sutro Biopharma, Maintains $54 Price Target on Differentiated ADC Platform and Pipeline Progress
1h ago
STRO
Sutro Biopharma price target raised to $10 from $9 at BofA
PremiumThe Fly
Sutro Biopharma price target raised to $10 from $9 at BofA
4d ago
STRO
Sutro Biopharma: Buy Rating on Strong ADC Execution, Cash Runway Into 2028, and Multiple 2026 Catalysts
PremiumRatings
Sutro Biopharma: Buy Rating on Strong ADC Execution, Cash Runway Into 2028, and Multiple 2026 Catalysts
11d ago
STRO
Wedbush upgrades Sutro Biopharma to Outperform, raises price target to $60
PremiumThe Fly
Wedbush upgrades Sutro Biopharma to Outperform, raises price target to $60
11d ago
STRO
Sutro Biopharma upgraded to Outperform from Neutral at Wedbush
PremiumThe Fly
Sutro Biopharma upgraded to Outperform from Neutral at Wedbush
11d ago
STRO
Sutro Biopharma price target raised to $50 from $28 at H.C. Wainwright
PremiumThe FlySutro Biopharma price target raised to $50 from $28 at H.C. Wainwright
11d ago
STRO
Sutro Biopharma price target raised to $43 from $38 at Leerink
Premium
The Fly
Sutro Biopharma price target raised to $43 from $38 at Leerink
11d ago
STRO
Analyst Reiterates Buy on Sutro Biopharma, Citing STRO-004 Phase I Readout and Broader ADC Platform Potential
Premium
Ratings
Analyst Reiterates Buy on Sutro Biopharma, Citing STRO-004 Phase I Readout and Broader ADC Platform Potential
12d ago
STRO
Sutro Biopharma reports Q1 EPS ($2.94), consensus ($3.21)
PremiumThe Fly
Sutro Biopharma reports Q1 EPS ($2.94), consensus ($3.21)
12d ago
STRO
STRO Earnings this Week: How Will it Perform?
PremiumPre-Earnings
STRO Earnings this Week: How Will it Perform?
15d ago
STRO
Meta downgraded, Qualcomm upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Meta downgraded, Qualcomm upgraded: Wall Street’s top analyst calls
26d ago
MG
RS
Sutro Biopharma initiated with an Outperform at Mizuho
PremiumThe Fly
Sutro Biopharma initiated with an Outperform at Mizuho
26d ago
STRO
Sutro Biopharma price target raised to $41 from $35 at Citizens
PremiumThe FlySutro Biopharma price target raised to $41 from $35 at Citizens
1M ago
STRO
Sutro Biopharma presents preclinical data across its pipeline of ADCs
Premium
The Fly
Sutro Biopharma presents preclinical data across its pipeline of ADCs
1M ago
STRO
Sutro Biopharma price target raised to $35 from $23 at Citizens
Premium
The Fly
Sutro Biopharma price target raised to $35 from $23 at Citizens
1M ago
STRO
Sutro Biopharma management to meet with Citizens
PremiumThe Fly
Sutro Biopharma management to meet with Citizens
1M ago
STRO
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
PremiumThe Fly
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
2M ago
GILD
IMNM
Arm downgraded, Arista Networks upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Arm downgraded, Arista Networks upgraded: Wall Street’s top analyst calls
2M ago
ARM
WAL
Sutro Biopharma initiated with an Outperform at Leerink
PremiumThe Fly
Sutro Biopharma initiated with an Outperform at Leerink
2M ago
STRO
Sutro Biopharma price target raised to $55 from $51 at Deutsche Bank
PremiumThe FlySutro Biopharma price target raised to $55 from $51 at Deutsche Bank
2M ago
STRO
Sutro Biopharma Faces Rising Operational Risks Amid Escalating U.S.-China Trade Tensions
Premium
Company Announcements
Sutro Biopharma Faces Rising Operational Risks Amid Escalating U.S.-China Trade Tensions
2M ago
STRO
Sutro Biopharma upgraded to Buy from Neutral at H.C. Wainwright
Premium
The Fly
Sutro Biopharma upgraded to Buy from Neutral at H.C. Wainwright
2M ago
STRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >